Pura Vida Investments’s Rocket Pharmaceuticals RCKT Stock Holding History

Pura Vida Investments’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$921K	–	236
2022 Q3	$798K	Buy	+50,000	New	+$780K	0.05%	163
2020 Q1	–	Sell	-109,000	Closed	-$2.48M	–	127
2019 Q4	$2.48M	Buy	+109,000	New	+$1.82M	0.22%	76
2018 Q3	–	Sell	-51,459	Closed	-$1.01M	–	124
2018 Q2	$1.01M	Sell	51,459 -20,000	-28%	-$378K	0.4%	69
2018 Q1	$1.34M	Buy	+71,459	New	+$1.17M	0.79%	41
2016 Q4	–	Sell	-27,867	Closed	-$1.06M	–	87
2016 Q3	$1.06M	Buy	27,867 +9,117	+49%	+$287K	0.32%	69
2016 Q2	$558K	Hold	18,750	–	–	0.24%	64
2016 Q1	$555K	Buy	18,750 +12,050	+180%	+$362K	0.25%	66
2015 Q4	$304K	Hold	6,700	–	–	0.13%	72
2015 Q3	$252K	Buy	+6,700	New	+$308K	0.14%	63
2015 Q2	–	Sell	-21,875	Closed	-$474K	–	80
2015 Q1	$474K	Buy	+21,875	New	+$513K	0.24%	55

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pura Vida Investments's RCKT Position: Q4 2022 in Review

Pura Vida Investments sold out of Rocket Pharmaceuticals (RCKT) in Q4 2022, closing a stake of 50,000 shares — an estimated $921K sold.

Pura Vida Investments first reported a position in RCKT in Q1 2015 and held it in 10 quarters. The position peaked at $2.48M in Q4 2019. 168 funds tracked by Wall St. Rank hold RCKT as of Q4 2022.

Pura Vida Investments reported no remaining Rocket Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Pura Vida Investments sold 50,000 Rocket Pharmaceuticals shares in Q4 2022, an estimated $921K.
Pura Vida Investments first reported a position in Rocket Pharmaceuticals in Q1 2015 and held it in 10 quarters.
Pura Vida Investments's Rocket Pharmaceuticals position peaked at $2.48M in Q4 2019.
168 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.